fluoroerythronitroimidazole

Known as: FETNIM 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2016
01219952016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
PURPOSE This is a clinical study to compare noninvasive hypoxia imaging using 18F-fluoroerythronitroimidazole (18F-FETNIM) and… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2013
2013
PURPOSE (18)F-fluoroerythronitroimidazole ((18)F-FETNIM) PET/CT allows a noninvasive assessment of tumor hypoxia. The purpose of… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2012
2012
The purpose of this study was to evaluate hypoxia in esophageal squamous cell carcinoma (SCC) with (18)F… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
PURPOSE Our aims were to assess the feasibility of imaging hypoxia in cervical carcinoma with (18)F-fluoroerythronitroimidazole… (More)
Is this relevant?
2010
2010
INTRODUCTION The aim of this study was to compare glucose metabolism and hypoxia using 18F- fluorodeoxyglucose (18F-FDG) and 18F… (More)
Is this relevant?
Review
2008
Review
2008
Non-invasive detection of tumor hypoxia using radiolabeled 2-nitroimidazoles has been a major effort during the last two decades… (More)
Is this relevant?
2001
2001
UNLABELLED Hypoxia is a characteristic feature of malignant tumors that should be evaluated before the start of therapy. (18)F… (More)
Is this relevant?
2001
2001
UNLABELLED 18F-labeled fluoroerythronitroimidazole (FETNIM) has been suggested as a marker of tumor hypoxia for use with PET. Our… (More)
Is this relevant?
1999
1999
The purpose of this study was to evaluate the effect of tumor size on the uptake of 18F-fluorodeoxyglucose (FDG) and… (More)
Is this relevant?
1995
1995
PURPOSE To develop a hydrophilic ligand to image tumor hypoxia at positron emission tomography (PET). MATERIALS AND METHODS… (More)
Is this relevant?